At GINN, our mission is to drive science-based, harm reduction-focused regulation for novel nicotine products across the globe. Explore how our presence in key regions is shaping the future of nicotine innovation and public health policy.
Regional Divisions
🌏 European Union (EU)
GINN is actively shaping the future of nicotine regulation in the EU. As updates to the Tobacco Products Directive (TPD3) and Excise Directive (TED) approach, we work to ensure nicotine pouches are treated fairly—based on science, not stigma.
Led by Jacobo Truan Aguirre, we engage with policymakers, promote risk-based rules, and support a balanced regulatory framework that protects public health while allowing innovation.
🌏 Middle East & North Africa (MENA)
GINN MENA is committed to promoting safer nicotine alternatives through science-based regulation, education, and advocacy. With smoking rates still high in many MENA countries, our goal is to support harm reduction by working with local policymakers, healthcare professionals, and industry leaders.
Led by Associate Director Joe Sakr, GINN MENA builds on regional momentum—especially in Saudi Arabia and the UAE—to encourage responsible innovation and public health solutions tailored to cultural and regulatory contexts.
🌏 Asia-Pacific (APAC)
Pioneering Smoke-Free Innovation in Asia
Welcome to our APAC division, where we lead the charge in smoke-free innovation across Asia and Oceania. This vibrant region is witnessing a burgeoning presence of nicotine alternatives, and we are at the forefront of driving this transformative change.
Led by our Director, Shem Baldeosingh, an expert with extensive experience in both commercial and government affairs across Australia, New Zealand, the Pacific Islands, and Timor-Leste, GINN is uniquely positioned to navigate the intricate landscape of nicotine alternatives. Shem’s deep understanding of New Zealand’s regulatory and commercial environments enriches our approach, ensuring that we meet the dynamic needs of this region effectively.
🌏 New Zealand: A Hub for Regulatory Excellence and Commercial Growth
Under the umbrella of APAC, our New Zealand page showcases a nation where innovation in nicotine alternatives thrives amidst a robust regulatory framework. With our Director, Shem Baldeosingh, as the focal point—bringing unparalleled insight into New Zealand’s regulatory landscape and commercial strategies—we are stepping forward to shape a smoke-free future.
Explore how we leverage our local expertise to spearhead initiatives that align with New Zealand’s evolving market demands, creating impactful solutions that resonate globally.
Join us as we pioneer smoke-free advancements across Asia and support a healthier tomorrow.